Current Headlines

  1. Philips Sets Up IPO For Lighting Biz To Jumpstart HealthTech
    5/4/2016

    Royal Philips has set in motion its protracted plan to focus on healthcare by announcing that it will sell its traditional lighting business through an initial public offering (IPO).

  2. Sinocare Pays $290M For PTS Diagnostics, Expands Diabetes Business
    5/4/2016

    Sinocare, a Chinese medtech specializing in the development and manufacture of biosensor technology, has inked a deal to acquire U.S.-based PTS Diagnostics and its portfolio of point-of-care (POC) biometric testing devices. The $290-million deal expands Sinocare’s global foothold in the diabetes management market.

  3. Alphabet Files Patent For Bionic Eye, Artificial Lens Implant
    5/3/2016

    Alphabet has filed a patent application for a corrective smart lens that would inject into the eyeball and conform to the inside surface of the eye’s lens capsule, following removal of the natural lens. According to the application, the device can be controlled by natural movements of the eye and by the lens itself, which is powered by an external antenna.

  4. Pfizer Reportedly Taking Bids For Hospira
    5/3/2016

    Pharmaceutical giant Pfizer is reportedly accepting bids for its struggling Hospira business, but no deal is imminent. British engineering firm Smiths Group Plc and German healthcare company Fresenius SE are among those who have placed bids for Hospira, reports Bloomberg.

  5. Intraosseous Small Bone Fixation System Earns FDA Approval
    5/3/2016

    First Ray, a start-up medical device company focused on advanced surgical devices for improving outcomes for orthopaedic extremity procedures, announces that it has received FDA 510(k) clearance for its innovative Stealth Staple™ System.

  6. Medtronic's New Single-Chamber ICDs Detect Atrial Fibrillation
    5/2/2016

    Medtronic plc (NYSE: MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the Visia AF MRI SureScan and Visia AF single-chamber implantable cardioverter defibrillators (ICDs). The Visia AF devices can detect previously undiagnosed and/or asymptomatic atrial fibrillation (AF) and monitor recurrent AF, while treating life-threatening rhythms in the lower chambers of the heart. The Visia AF ICD systems will be commercially available in early summer.

  7. Dissolvable Circuitry For Medical Devices Developed From Egg Whites
    5/2/2016

    Using egg whites, magnesium, and tungsten, university scientists have developed a component of electrical circuitry that could be used in dissolvable implants or advanced drug delivery. Their lab tests showed that the circuits were as stable and reliable as non-degradable circuits and could be dissolved in water within 72 hours.

  8. Stryker Buys Orthopedic Oncology Firm Stanmore Implants For $52 Million
    5/2/2016

    Stryker Corporation added to its string of acquisitions this year with the recent purchase of Stanmore Implants, a United Kingdom-based manufacturer of reconstructive orthopedic devices for oncology patients, for $52 million (£35.6 million) in cash.

  9. Medtronic’s StrataMR Valves And Shunts Deemed MRI-Compatible By FDA
    5/2/2016

    Medtronic plc recently announced the U.S. Food and Drug Administration (FDA) clearance of StrataMR valves and shunts, an addition to Medtronic's family of Strata Adjustable Valve Systems used in the treatment of patients with hydrocephalus and cerebrospinal fluid (CSF) disorders.

  10. Abbott Pays $25 Billion For St. Jude Medical To Boost Device Business
    4/29/2016

    Abbott will acquire St. Jude Medical for $25 billion in cash and stock to significantly enhance its medical device business and cope with increasing price pressure from consolidating hospital clients.